The US had a rare year without a hurricane make landfall, but it saw too much extreme rainfall and flash flooding across the ...

Hikma Pharmaceuticals’ latest valuation update points to a slightly lower fair value estimate of about $22.66 per share, even as analysts broadly maintain a constructive view on its long term growth ...

Latest model runs suggest a cold spell is on the way between Christmas and the New Year. However a white Christmas in Wales ...